Status:
COMPLETED
High-Dose Therapy Treatment in Patients With Follicular Lymphoma
Lead Sponsor:
French Innovative Leukemia Organisation
Conditions:
Follicular Lymphoma
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Follicular lymphomas are a subgroup of B-cell non-Hodgkin lymphomas, accounting for 15% to 30% of newly diagnosed lymphomas.1-3 Median survival varies from 5 to 10 years depending on the prognostic fa...
Detailed Description
Age 8-60 years old follicular lymphoma Not previously treated Stage II bulky, III or IV An Arbor classification high tumor burden
Eligibility Criteria
Inclusion
- Age 18-60 years old
- Follicular Lymphoma B, C or D (Working Formulation)
- No previous treatment
- Seronegativity HIV
- ECOG performance status less than or 2
- eligible for autologous stem-cell transplantation
- Stage II , III or IV Ann Arbor Classification
- criterias of high tumor burden
- Patient's written informed consent
Exclusion
- Age less than 18 years old or more than 60 years old
- Other type of lymphoma
- Stage less than 3 or III-IV (faible masse)
- Seropositivity HIV
- Patients with a history of another malignancy except basal cell skin cancer or in situ uterus cancer
Key Trial Info
Start Date :
June 1 1994
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00696735
Start Date
June 1 1994
End Date
May 1 2006
Last Update
October 24 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emmanuel GYAN
Tours, France, 37000
2
Philippe COLOMBAT
Tours, France, 37000